Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „avanafil“
Suchtreffer
Begriffe & Kennungen
Spedra · 4.5 · Based on in vitro data, at clinically relevant concentrations avanafil could be an inhibitor of BCRP. At clini
Eintrag öffnenSpedra · 4.5 · CYP3A4 substrate Amlodipine (5 mg daily) increased avanafil 200 mg single-dose Cmax and AUC by approximately 2
Eintrag öffnenSpedra · 4.5 · CYP3A4 substrate Amlodipine (5 mg daily) increased avanafil 200 mg single-dose Cmax and AUC by approximately 2
Eintrag öffnenSpedra · 4.5 · CYP3A4 substrate Amlodipine (5 mg daily) increased avanafil 200 mg single-dose Cmax and AUC by approximately 2
Eintrag öffnenSpedra · 4.5 · Cytochrome P450 Induction The potential induction of CYP1A2, CYP2B6 and CYP3A4 by avanafil evaluated in primar
Eintrag öffnenSpedra · 4.5 · Cytochrome P450 Induction The potential induction of CYP1A2, CYP2B6 and CYP3A4 by avanafil evaluated in primar
Eintrag öffnenSpedra · 4.5 · Cytochrome P450 Induction The potential induction of CYP1A2, CYP2B6 and CYP3A4 by avanafil evaluated in primar
Eintrag öffnenSpedra · 4.5 · Effects of avanafil on other medicinal products Cytochrome P450 Inhibition In in vitro studies in human liver
Eintrag öffnenSpedra · 4.5 · Effects of avanafil on other medicinal products Cytochrome P450 Inhibition In in vitro studies in human liver
Eintrag öffnenSpedra · 4.5 · Effects of avanafil on other medicinal products Cytochrome P450 Inhibition In in vitro studies in human liver
Eintrag öffnenSpedra · 4.5 · Effects of other substances on avanafil Avanafil is a substrate of and predominantly metabolised by CYP3A4. St
Eintrag öffnenSpedra · 4.5 · Effects of other substances on avanafil Avanafil is a substrate of and predominantly metabolised by CYP3A4. St
Eintrag öffnenSpedra · 4.5 · Effects of other substances on avanafil Avanafil is a substrate of and predominantly metabolised by CYP3A4. St
Eintrag öffnenSpedra · 4.5 · Erythromycin (500 mg twice daily), a moderate CYP3A4 inhibitor, increased avanafil 200 mg single- dose Cmax an
Eintrag öffnenSpedra · 4.5 · Erythromycin (500 mg twice daily), a moderate CYP3A4 inhibitor, increased avanafil 200 mg single- dose Cmax an
Eintrag öffnenSpedra · 4.5 · Erythromycin (500 mg twice daily), a moderate CYP3A4 inhibitor, increased avanafil 200 mg single- dose Cmax an
Eintrag öffnenSpedra · 4.5 · Medicinal products reducing systemic blood pressure As a vasodilator, avanafil may reduce systemic blood press
Eintrag öffnenSpedra · 4.5 · Medicinal products reducing systemic blood pressure As a vasodilator, avanafil may reduce systemic blood press
Eintrag öffnenSpedra · 4.5 · Medicinal products reducing systemic blood pressure As a vasodilator, avanafil may reduce systemic blood press
Eintrag öffnenSpedra · 4.5 · Other treatments for erectile dysfunction The safety and efficacy of combinations of avanafil and other PDE5 i
Eintrag öffnen